Two limbs might need to be lopped off. One is the diseased $65bn of dodgy debt securities. Sadly, to pay for the hit, Lehman could also have to cut off its healthy fund management arm.Sign up to read the rest of this subscriber-only content, or if you are already a member please sign in here.
Forgotten your password? Get a password reminder.
This Views Flash will shortly be followed by a Considered View